CD48 is an allergen and IL-3-induced activation molecule on eosinophils

Journal of Immunology

Volumn 177, Issue 1, 2006, Pages 77-83

  Munitz, Ariel ^a   Bachelet, Ido ^a   Eliashar, Ron ^b   Khodoun, Marat ^c   Finkelman, Fred D ^c   Rothenberg, Marc E ^c   Levi Schaffer, Francesca ^a,d  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b HEBREW UNIVERSITY   (Israel)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^d HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; CD2 ANTIGEN RECEPTOR 2B4; CD48 ANTIGEN; CHEMOKINE; CYTOKINE; EOSINOPHIL GRANULE PROTEIN; GLYCOSYLPHOSPHATIDYLINOSITOL; INTERLEUKIN 3; LIGAND; UNCLASSIFIED DRUG;

ALLERGIC ASTHMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ACTIVATION; CELL ADHESION; CELL INTERACTION; CONTROLLED STUDY; DISEASE MODEL; EOSINOPHIL; FEMALE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN EXPRESSION; PROTEIN FUNCTION; RESPIRATORY TRACT INFLAMMATION; UPREGULATION;

EID: 33745305895     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.1.77     Document Type: Article

References (50)

1. Rothenberg, M. E., and S. P. Hogan. 2006. The eosinophil. Annu. Rev. Immunol. 24: 147-174.
2. Weller, P. F. 1991. The immunobiology of eosinophils. N. Engl. J. Med. 324: 1110-1118.
3. Munitz, A., and F. Levi-Schaffer. 2004. Eosinophils: new roles for old cells. Allergy 59: 268-275.
4. Tedla, N., C. Banderia-Melo, P. Tassinari, D. E. Sloane, M. Samplaski, D. Cosman, L. Borges, P. F. Weller, and J. P. Arm. 2003. Activation of human eosinophils through leukocyte immunoglobulin-like receptor 7. Proc. Natl. Acad. Sci. USA 100: 1174-1179.
5. Nutku, E., H. Aizawa, S. A. Hudson, and B. S. Bochner. 2003. Ligation of Siglec-8: a selective mechanism for induction of human eosinophil apoptosis. Blood 101: 5014-5020.
6. Munday, J., S. Kerr, J. Ni, A. L. Cornish, J. Q. Zhang, G. Nicoll, H. Floyd, M. G. Mattei, P. Moore, D. Liu, and P. R. Crocker. 2001. Identification characterization and leukocyte expression of Siglec-10, a novel human sialic acid-binding receptor. Biochem. J. 355: 489-497.
7. Munitz, A., I. Bachelet, R. Eliashar, A. Moretta, L. Moretta, and F. Levi-Schaffer. 2006. The inhibitory receptor IRp60 (CD300a) suppresses the effects of IL-5, GM-CSF and eotaxin on human peripheral blood eosinophils. Blood 107: 1996-2003.
8. Moretta, A., C. Bottino, M. Vitale, D. Pende, C. Cantoni, M. C. Mingari, R. Biassoni, and L. Moretta. 2001. Activating receptors and coreceptors involved in human natural killer cell mediated cytolysis. Annu. Rev. Immunol. 19: 197-223.
9. Sidorenko, S. P., and E. A. Clark. 2003. The dual-function CD150 receptor subfamily: the viral attraction. Nat. Immunol. 4: 19-24.
10. Munitz, A., I. Bachelet, S. Fraenkel, G. Katz, O. Mandelboim, H. U. Simon, L. Moretta, M. Colonna, and F. Levi-Schaffer. 2005. 2B4 (CD244) is expressed and functional on human eosinophils. J. Immunol. 174: 110-118.
11. Boles, K. S., S. E. Stepp, M. Bennett, V. Kumar, and P. A. Mathew. 2001. 2B4 (CD244) and CS1: novel members of the CD2 subset of the immunoglobulin superfamily molecules expressed on natural killer cells and other leukocytes. Immunol. Rev. 181: 234-249.
12. Smith, G. M., J. Biggs, B. Norris, P. Anderson-Stewart, and R. Ward. 1997. Detection of a soluble form of the leukocyte surface antigen CD48 in plasma and its elevation in patients with lymphoid leukemias and arthritis. J. Clin. Immunol. 17: 502-509.
13. Stefanova, I., V. Horejsi, I. J. Ansotegui, W. Knapp, and H. Stockinger. 1991. GPI-anchored cell-surface molecules complexed to protein tyrosine kinases. Science 254: 1016-1019.
14. Katsuura, M., Y. Shimizu, K. Akiba, C. Kanazawa, T. Mitsui, D. Sendo, T. Kawakami, K. Hayasaka, and S. Yokahama. 1998. CD48 expression on leukocytes in infectious diseases: flow cytometric analysis of surface antigen. Acta Paediatr. Jpn. 40: 580-585.
15. Van Rijt, L. S., H. Kuipers, N. Vos, D. Hijdra, H. C. Hoogsteden, and B. N. Lambrecht. 2004. A rapid flow cytometric method for determining the cellular composition of bronchoalveolar lavage fluid cells in mouse models of asthma. J. Immunol. Methods 288: 111-121.
16. Southam, D. S., N. Widmer, R. Ellis, J. A. Hirota, M. D. Inman, and R. Sehmi. 2005. Increased eosinophil-lineage committed progenitors in the lung of allergen-challenged mice. J. Allergy Clin. Immunol. 115: 95-102.
17. Abrams, J. S., M. G. Roncarolo, H. Yssel, U. Andersson, G. J. Gleich, and J. E. Silver. 1992. Strategies of anti-cytokine monoclonal antibody development: immunoassay of IL-10 and IL-5 in clinical samples. Immunol. Rev. 127: 5-24.
18. Dent, L. A., M. Strath, A. L. Mellor, and C. J. Sanderson. 1990. Eosinophilia in transgenic mice expressing interleukin 5. J. Exp. Med. 172: 1425-1431.
19. Finkelman, F. D., K. B. Madden, S. C. Morris, J. M. Holmes, N. Boiani, I. M. Katona, and C. R. Maliszewski. 1993. Anti-cytokine antibodies as carrier proteins: prolongation of in vivo effects of exogenous cytokines by injection of cytokine-anti-cytokine antibody complexes. J. Immunol. 151: 1235-1244.
20. Khoudon, M. V., T. Orekhova, C. Potter, S. Morris, and F. D. Finkelman. 2004. Basophils initiate IL-4 production during a memory T-dependent response. J. Exp. Med. 200: 857-870.
21. Eliashar, R., and F. Levi-Schaffer. 2005. The role of the eosinophil in nasal diseases. Curr. Opin. Otolaryngol. Head Neck Surg. 13: 171-175.
22. + T cell activation. Proc. Natl. Acad Sci. USA 96: 1019-1023.
23. Finkelman, F. D., and S. C. Morris. 1999. Development of an assay to measure in vivo cytokine production in the mouse. Int. Immunol. 11: 1811-1818.
24. Bochner, B. S. 2004. Verdict in the case of therapies versus eosinophils: the jury is still out. J. Allergy Clin. Immunol. 113: 3-9.
25. Braunstahl, G. J., and W. Fokkens. 2003. Nasal involvement in allergic asthma. Allergy 58: 1235-1243.
26. Giembycz, M. A., and M. A. Lindsay. 1999. The pharmacology of the eosinophil. Pharmacol. Rev. 51: 213-340.
27. Celestin, J., O. Rotschke, K. Falk, N. Ramesh, H. Jabara, J. Strominger, and R. S. Geha. 2001. IL-3 induces B7.2 (CD86) expression and costimulatory activity in human eosinophils. J. Immunol. 167: 6097-6104.
28. Dulkys, Y., C. Kluthe, T. Buschermohle, I. Barg, S. Knoss, A. Kapp, A. E. Proudfoot, and J. Elsner. 2001. IL-3 induces down-regulation of CCR3 protein and mRNA in human eosinophils. J. Immunol. 167: 3443-3453.
29. Yoshimura, C., M. Yamaguchi, M. Iikura, S. Izumi, K. Kudo, H. Nagase, A. Ishii, A. F. Walls, C. Ra, T. Iwata, et al. 2002. Activation markers of human basophils: CD69 expression is strongly and preferentially induced by IL-3. J. Allergy Clin. Immunol. 109: 817-823.
30. Mire-Sluis, A., L. A. Page, M. Wadhwa, and R. Thorpe. 1995. Evidence for a signaling role for the α chains of granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-3 (IL-3), and IL-5 receptors: divergent signaling pathways between GM-CSF/IL-3 and IL-5. Blood 86: 2679-2688.
31. Gregory, B., A. Kirchem, S. Phipps, P. Gevaert, C. Pridgeosn, S. M. Rankin, and D. S. Robinson. 2003. Differential regulation of human eosinophil IL-3, IL-5, and GM-CSF receptor α-chain expression by cytokines: IL-3, IL-5, and GM-CSF down-regulate IL-5 receptor α expression with loss of IL-5 responsiveness, but up-regulate IL-3 receptor α expression. J. Immunol. 170: 5359-5366.
32. Tissot, C., C. Rebouissou, B. Klein, and N. Mechti. 1997. Both human αβ and γ interferons upregulate the expression of CD48 cell surface molecules. J. Interferon Cytokine Res. 17: 17-26.
33. Yokoyama, S., D. Staunton, R. Fisher, M. Amiot, J. J. Fortin, and D. A. Thorley-Lawson. 1991. Expression of the Blast-1 activation/adhesion molecule and its identification as CD48. J. Immunol. 146: 2192-2200.
34. Rothenberg, M. E., W. F. Owen, Jr., D. S. Silberstein, J. Woods, R. J. Soberman, K. F. Austen, and R. L. Stevens. 1988. Human eosinophils have prolonged survival, enhanced functional properties, and become hypodense when exposed to human interleukin 3. J. Clin. Invest. 81: 1986-1992.
35. Shin, J. S., and S. N. Abraham. 2001. Glycosylphosphatidylinositol- anchored receptor-mediated bacterial endocytosis. FEMS Microbiol. Lett. 197: 131-138.
36. Horejsi, V., K. Drbal, M. Cebecauer, J. Cerny, T. Brdicka, P. Angelisova, and H. Stockinger. 1999. GPI-microdomains: a role in signalling via immunoreceptors. Immunol. Today 20: 356-361.
37. fyn with the glycosyl phosphatidylinositol-anchored proteins Thy-1 and CD48 in rat thymocytes is dependent on the state of cellular activation. Eur. J. Immunol. 23: 2540-2544.
38. + and inositol trisphosphate concentrations in murine T lymphocytes by the glycosylphosphatidylinositol-anchored protein sgp-60. J. Immunol. 150: 3198-3206.
39. Reiser, H. 1990. sgp-60, a signal-transducing glycoprotein concerned with T cell activation through the T cell receptor/CD3 complex. J. Immunol. 145: 2077-2086.
40. Klyushnenkova, E. N., L. Li, R. J. Armitage, and Y. S. Choi. 1996. CD48 delivers an accessory signal for CD40-mediated activation of human B cells. Cell. Immunol. 174: 90-98.
41. Moran, M., and M. C. Miceli. 1988. Engagement of GPI-linked CD48 contributes to TCR signals and cytoskeletal reorganization: a role for lipid rafts in T cell activation. Immunity 9: 787-796.
42. Hoffmann, J. C., H. Kruger, S. Zielen, B. Bayer, and H. Zeidler. 1998. Human B cell differentiation: dependence on interactions with monocytes and T lymphocytes via CD40, CD80 (B7.1), and the CD2-ligands CD48 and CD58 (LFA-3). Cell Biol. Int. 22: 21-29.
43. Garnett, D., and A. F. Williams. 1994. Homotypic adhesion of rat B cells, but not T cells, in response to cross-linking of CD48. Immunology 81: 103-110.
44. Ianelli, C. J., R. DeLellis, and D. A Thorley-Lawson. 1998. CD48 binds to heparan sulfate on the surface of epithelial cells. J. Biol. Chem. 273: 23367-23375.
45. Lee, N. A., E. W. Gelfand, and J. J. Lee. 2001. Pulmonary T cells and eosinophils: coconspirators or independent triggers of allergic respiratory pathology? J. Allergy Clin. Immunol. 107: 945-957.
46. 2-microglobulin-deficient mice have hybrid phenotype and function of NK and T cells. J. Immunol. 172: 6115-6122.
47. Akbari, O., P. Stock, E. Meyer, M. Kronenberg, S. Sidobre, T. Nakayama, M. Taniguchi, M. J. Grusby, R. H. DeKruyff, and D. T. Umetsu. 2003. Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity. Nat. Med. 9: 582-588.
48. Woerly, G., N. Roger, S. Loiseau, D. Dombrowicz, A. Capron, and M. Capron. 1999. Expression of CD28 and CD86 by human eosinophils and role in the secretion of type 1 cytokines (interleukin 2 and interferon γ): inhibition by immunoglobulin A complexes. J. Exp. Med. 190: 487-495.
49. Shi, H. Z., A. Humbles C. Gerard, Z. Jin, and P. F. Weller. 2000. Lymph node trafficking and antigen presentation by endobronchial eosinophils. J. Clin. Invest. 105: 945-953.
50. Shen, H. H., S. I. Ochkur, M. P. McGarry, J. R. Crosby, E. M. Hines, M. T. Borchers, H. Wang, T. L. Biechelle, K. R. O'Neill, T. L. Ansay, et al. 2003. A causative relationship exists between eosinophils and the development of allergic pulmonary pathologies in the mouse. J. Immunol. 170: 3296-3305.